Employers Reduce Coverage of Weight-Loss Drugs Amid Rising Costs
Large employers are scaling back or eliminating coverage for weight-loss drugs like Wegovy (Novo Nordisk) and Zepbound (Eli Lilly), as surging demand drives up healthcare costs. This shift reflects growing financial pressure on employer-sponsored health plans.
Topics: cost containment employer healthcare coverage weight-loss drugs